The effect of vaccination to dendritic cell and immune cell interaction in HIV disease progression

被引:10
|
作者
Roy, Priti Kumar [1 ]
Chatterjee, Amar Nath [1 ]
Li, Xue-Zhi [2 ]
机构
[1] Jadavpur Univ, Dept Math, Ctr Math Biol & Ecol, Kolkata 700032, India
[2] Xinyang Normal Univ, Coll Math & Informat Sci, Xinyang 464000, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV; dendritic cell; DC-based immune therapy; first-order elimination; Michaelis-Menten elimination; IMMUNOLOGICAL MODEL; DRUG; INFECTION; DYNAMICS; PROTEASE; THERAPY;
D O I
10.1142/S1793524516500054
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this research paper, our main objective is to find out the meticulous role of activated dendritic cells (DCs) during the human immunodeficiency virus (HIV) infection process. DCs play a dual role by enhancing both HIV infection progression, as well as antiviral immune response. To explore the implications of these dual roles, we have formulated our mathematical model and analyzed the model by both analytical and numerical approaches. By using an impulsive differential equation, we have studied the effect of DC-based vaccination. Analytically we have determined the threshold value of drug dosage and dosing interval for optimum levels of infection. We have also investigated the effect of perfect adherence of drug dose on the immune cell count in extreme cases and observed that, systematic drug dose of the immune cells leads to its maximum level.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] DENDRITIC CELL VACCINATION AND IMMUNE MONITORING
    de Vries, I. J. M.
    Adema, G. J.
    Punt, C. J. A.
    Figdor, C. G.
    Aamtzen, E. H. J. G.
    VOX SANGUINIS, 2009, 96 : 1 - 1
  • [2] Dendritic cell vaccination and immune monitoring
    E. H. J. G. Aarntzen
    C. G. Figdor
    G. J. Adema
    C. J. A. Punt
    I. J. M. de Vries
    Cancer Immunology, Immunotherapy, 2008, 57 : 1559 - 1568
  • [3] Dendritic cell vaccination and immune monitoring
    Aarntzen, E. H. J. G.
    Figdor, C. G.
    Adema, G. J.
    Punt, C. J. A.
    de Vries, I. J. M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (10) : 1559 - 1568
  • [4] Dendritic cell vaccination and immune monitoring
    Aarntzen, E. H. J. G.
    Figdor, C. G.
    Adema, G. J.
    Punt, C. J. A.
    de Vries, I. J. M.
    ISBT SCIENCE SERIES, VOL 4, NO 1, STATE OF THE ART PRESENTATIONS, 2009, 4 (01): : 18 - +
  • [5] Dendritic cell vaccination in autoimmune disease
    Gross, Catharina C.
    Wiendl, Heinz
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (02) : 268 - 274
  • [6] Dendritic Cell Status Modulates the Outcome of HIV-Related B Cell Disease Progression
    Poudrier, Johanne
    Roger, Michel
    PLOS PATHOGENS, 2011, 7 (08):
  • [7] Dendritic Cell-Based Therapeutic Vaccination for HIV
    Benito, Jose M.
    AIDS REVIEWS, 2013, 15 (01) : 62 - 62
  • [8] Interaction of tumor cells with the immune system: implications for dendritic cell therapy and cancer progression
    Imhof, Marianne
    Karas, Irene
    Gomez, Ivan
    Eger, Andreas
    Imhof, Martin
    DRUG DISCOVERY TODAY, 2013, 18 (1-2) : 35 - 42
  • [9] HIV/Dendritic Cell Interaction: Consequences in the Pathogenesis of HIV Infection
    Barroca, Pedro
    Calado, Marta
    Azevedo-Pereira, Jose M.
    AIDS REVIEWS, 2014, 16 (04) : 223 - 235
  • [10] A Comparative Study of the Intratumor Immune Effect of DendritIc Cell Vaccination and the Conventional Treatment in Glioblastoma
    Idoate, Miguel
    Arana, Inigo
    Diez-Valle, Ricardo
    Inoges, Susana
    Lopez, Ascension
    Echeveste, Jose
    Lozano, Maria
    Tejada, Sonia
    Guillen Grima, Francisco
    LABORATORY INVESTIGATION, 2015, 95 : 431A - 431A